Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for Orthostatic Hypotension After Bariatric Surgery
IRCT20250825066986N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midodrine in orthostatic hypotension (OH), sponsored by Shiraz University of Medical Sciences. Started Dec 2024; status: completed.
02
Drugs
midodrine
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on IRCT20250825066986N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250825066986N1.